跳至主要内容
临床试验/ACTRN12619000757112
ACTRN12619000757112已完成未知

The effect of intermittent fasting on integrated muscle protein synthesis rates in overweight, middle-aged men

Australian Catholic University0 个研究点目标入组 37 人开始时间: 2019年5月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
35 Years 至 55 Years(—)
性别
Male

入选标准

  • - Age: 35-55 years
  • - BMI: 25-35 kg/m2

排除标准

  • 1)Current diagnosis of Type 2 Diabetes (HbA1C >6.5% or 48 mmol/mol)
  • 2)Unable to attend the laboratory for visits and adhere to the 3-day lead-in diet and 10-day intervention diet
  • 3)Currently meeting physical activity guidelines (i.e. doing more than 150 min of physical activity per week or >10,000 steps per day)
  • 4)Major or chronic illness that impairs mobility or eating/digestion;
  • 5)Previous bariatric surgery;
  • 6)Shift workers;
  • 7)Smoker (cigarette, e-cigarette or marijuana);
  • 8)Individuals with strict dietary intake regimes (i.e. vegan, avoidance of principal study foods);
  • 9)Individuals who are currently restricting their dietary intake (i.e. actively trying to diet and lose weight) or participating in regular fasting (defined as fasting >16 h/day or having completed twelve 24-h fasts within the past year);
  • 10)Participating in shift work (i.e. >3 h between 22:00 h and 05:00 h for 1 day per week (>50 days per year))
  • 11)Not weight stable (>5 kg body weight change over last 3 months);
  • 12)Individuals who do not consume breakfast on at least 5 of 7 days per week (i.e. not eating regular meals);
  • 13)On prescribed medications required to be taken with food in the early morning or late evening or taking other prescribed medications for <3 months.
  • 14)On prescribed anti coagulation medications (interfering with muscle biopsy procedures)

研究者

相似试验